Landscapes / Targets
erythropoietin (EPO)
3 drugs act on erythropoietin (EPO), in 3 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
QLG1218not checked |
— |
Phase 3 | May 2027Phase 3 trial completes | ||
| Next date | May 2027 · Phase 3 trial completes | ||||
| Also tested for | Anaemia | ||||
| Open drug page | |||||
— |
3SBio · Public 1530.HK |
Phase 2 | 1 Dec 2027Phase 2 trial completes | ||
| Next date | 1 Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Chemotherapy-induced Anemia, Non-myeloid Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Pharmacokinetics and Pharmacodynamics in Healthy Volunteers | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 3 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026